An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils
Clinical trial NCT02501629 · COMPLETED
Trial details
- NCT number
- NCT02501629
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-29
- Primary completion
- 2017-06-19
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.